Medication info

Rialbis Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Round white film-coated tablet
Packaging
300 tablets/bottle
Approval status
Expired

MFDS item code 201905508 · Approved 2019.08.05

This product's status changed to Expired on 2024.08.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers and gastritis); prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dosage is the same for ulcers caused by nonsteroidal anti-inflammatory drugs and for concomitant treatment to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets four times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets three times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers and gastritis); prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • reflux esophagitis
  • Mendelson's syndrome
  • postoperative ulcer
  • gastric ulcer caused by NSAIDs
  • duodenal ulcer caused by NSAIDs
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, gastritis, and Zollinger-Ellison syndrome. It is also effective for the prevention of reflux esophagitis and postoperative ulcers. It assists in treating ulcers of the stomach and duodenum caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to prevent Mendelson's syndrome when administered prior to anesthesia. This medication protects the gastric mucosa and regulates gastric acid secretion, contributing to symptom improvement. Overall, it is used for the treatment of various gastric-related diseases.

How to take

Adult dose

○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dosage is the same for ulcers caused by nonsteroidal anti-inflammatory drugs and for concomitant treatment to prevent gastric or duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets four times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets three times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or with impaired kidney function. It should also not be administered to patients who have had allergic reactions to this medication or its components. Patients with a history of acute porphyria should avoid this medication as it may worsen symptoms. It is also not recommended for patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants and newborns, and patients on a diet restricting potassium intake. Patients with impaired liver function or a history of drug allergies, elderly patients, and those with a history of renal disease should use this medication with caution. If taken in conjunction with NSAIDs, elderly patients or those with a history of peptic ulcers require regular monitoring. This medication can mask symptoms of gastric cancer, so patients with gastric ulcers or those over middle age experiencing new dyspeptic symptoms should ensure that it is not a malignant condition before administration. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should undergo bacterial eradication therapy. Caution is required for severely ill ICU patients, those with hypophosphatemia, and patients with swallowing difficulties. Rarely, serious allergic reactions such as anaphylactic shock may occur during this medication, so if symptoms appear, administration should be stopped immediately and medical personnel notified. Discontinue medication if hypersensitivity reactions, such as skin rash, urticaria, angioedema, fever, or difficulty breathing occur. Blood tests may show leukopenia or thrombocytopenia, so if symptoms such as fatigue, bleeding, or fever arise, testing should be conducted. If symptoms of liver dysfunction such as jaundice or fatigue occur, administration should be halted immediately. Cardiac arrhythmia has been rarely reported, so careful observation is needed for any unusual symptoms. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain. Neuropsychiatric symptoms such as dizziness, drowsiness, confusion, and seizures may also appear, so renal-impaired patients should be particularly cautious. Rarely reported symptoms include breast-related symptoms, myalgia, skin rash, and hair loss. If there is no therapeutic effect without long-term medication use, switch to other drugs, and conduct regular blood, liver, and kidney function tests during treatment. Caution is needed as the risk of pneumonia may increase in elderly patients or those with chronic lung disease or diabetes. If dizziness or drowsiness occurs after taking this medication, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so if you are taking any other medications, inform medical personnel, especially when combined with anticoagulants or certain antibiotics and anticonvulsants. Pregnant or breastfeeding women should not use this medication, and safety for children has not been established, so it is best not to administer it. In case of overdose, treatments such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis can be performed. This medication reduces gastric acid secretion and may promote bacterial growth in the stomach, thus requiring additional care, including ophthalmological examinations during long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 58 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • icteric hepatitis
  • non-icteric hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • feeling of illness
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • hypertrophic muscle spasms
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • joint pain
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that is air-tight and protected from direct sunlight at room temperature. Proper storage will help maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Round white film-coated tablet

Package unit

300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.